These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9557744

  • 1. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.
    Alymova IV, Kodihalli S, Govorkova EA, Fanget B, Gerdil C, Webster RG.
    J Virol; 1998 May; 72(5):4472-7. PubMed ID: 9557744
    [Abstract] [Full Text] [Related]

  • 2. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA, Kodihalli S, Alymova IV, Fanget B, Webster RG.
    Dev Biol Stand; 1999 May; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K, Kumihashi H, Nerome R, Hiromoto Y, Yokota Y, Ueda R, Omoe K, Chiba M.
    Dev Biol Stand; 1999 May; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [Abstract] [Full Text] [Related]

  • 4. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.
    Kodihalli S, Justewicz DM, Gubareva LV, Webster RG.
    J Virol; 1995 Aug; 69(8):4888-97. PubMed ID: 7609057
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.
    Katz JM, Webster RG.
    J Infect Dis; 1989 Aug; 160(2):191-8. PubMed ID: 2760480
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, Yano T, Suga T, Kawakami C, Yamamoto M, Kajiyama K, Saito H, Shimada S, Watanabe S, Aoki S, Taira K, Kon M, Lin JH, Odagiri T.
    Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
    [Abstract] [Full Text] [Related]

  • 7. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D, Park KJ, Lee H, Cho EY, Kim MS, Hwang MH, Kim SI, Ahn DH.
    Virus Res; 2015 Jun 02; 204():40-6. PubMed ID: 25892718
    [Abstract] [Full Text] [Related]

  • 8. Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies.
    Buffin S, Peubez I, Barrière F, Nicolaï MC, Tapia T, Dhir V, Forma E, Sève N, Legastelois I.
    Vaccine; 2019 Oct 31; 37(46):6857-6867. PubMed ID: 31590935
    [Abstract] [Full Text] [Related]

  • 9. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P, Zheng M, Lau SY, Chen P, Mok BW, Liu S, Liu H, Huang X, Cremin CJ, Song W, Chen Y, Wong YC, Huang H, To KK, Chen Z, Xia N, Yuen KY, Chen H.
    mBio; 2019 Sep 17; 10(5):. PubMed ID: 31530680
    [Abstract] [Full Text] [Related]

  • 10. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation.
    Saito T, Nakaya Y, Suzuki T, Ito R, Saito T, Saito H, Takao S, Sahara K, Odagiri T, Murata T, Usui T, Suzuki Y, Tashiro M.
    J Med Virol; 2004 Oct 17; 74(2):336-43. PubMed ID: 15332284
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L, Kays SK, Zimmer G, von Messling V.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925654
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.
    Wood JM, Oxford JS, Dunleavy U, Newman RW, Major D, Robertson JS.
    Virology; 1989 Jul 01; 171(1):214-21. PubMed ID: 2741341
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines.
    Guthmiller JJ, Utset HA, Henry C, Li L, Zheng NY, Sun W, Costa Vieira M, Zost S, Huang M, Hensley SE, Cobey S, Palese P, Wilson PC.
    mBio; 2021 Jun 29; 12(3):e0083821. PubMed ID: 34126773
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model.
    Jacobsen H, Rajendran M, Choi A, Sjursen H, Brokstad KA, Cox RJ, Palese P, Krammer F, Nachbagauer R.
    mBio; 2017 Sep 19; 8(5):. PubMed ID: 28928215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.